132 related articles for article (PubMed ID: 28833841)
1. Proposed biopsy performance benchmarks for MRI based on an audit of a large academic center.
Sedora Román NI; Mehta TS; Sharpe RE; Slanetz PJ; Venkataraman S; Fein-Zachary V; Dialani V
Breast J; 2018 May; 24(3):319-324. PubMed ID: 28833841
[TBL] [Abstract][Full Text] [Related]
2. Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.
Strigel RM; Rollenhagen J; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski L; DeMartini WB
Acad Radiol; 2017 Apr; 24(4):411-417. PubMed ID: 27986508
[TBL] [Abstract][Full Text] [Related]
3. Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI.
Niell BL; Gavenonis SC; Motazedi T; Chubiz JC; Halpern EP; Rafferty EA; Lee JM
J Am Coll Radiol; 2014 Sep; 11(9):883-9. PubMed ID: 24787571
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
Chikarmane SA; Tai R; Meyer JE; Giess CS
Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
[TBL] [Abstract][Full Text] [Related]
5. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Sprague BL; Arao RF; Miglioretti DL; Henderson LM; Buist DS; Onega T; Rauscher GH; Lee JM; Tosteson AN; Kerlikowske K; Lehman CD;
Radiology; 2017 Apr; 283(1):59-69. PubMed ID: 28244803
[TBL] [Abstract][Full Text] [Related]
6. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Lehman CD; Arao RF; Sprague BL; Lee JM; Buist DS; Kerlikowske K; Henderson LM; Onega T; Tosteson AN; Rauscher GH; Miglioretti DL
Radiology; 2017 Apr; 283(1):49-58. PubMed ID: 27918707
[TBL] [Abstract][Full Text] [Related]
7. Performance benchmarks for diagnostic mammography.
Sickles EA; Miglioretti DL; Ballard-Barbash R; Geller BM; Leung JW; Rosenberg RD; Smith-Bindman R; Yankaskas BC
Radiology; 2005 Jun; 235(3):775-90. PubMed ID: 15914475
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome assessment in mammography: an audit of 7,506 screening and diagnostic mammography examinations.
Tunçbilek I; Ozdemir A; Gültekin S; Oğur T; Erman R; Yüce C
Diagn Interv Radiol; 2007 Dec; 13(4):183-7. PubMed ID: 18092288
[TBL] [Abstract][Full Text] [Related]
9. A Simulation Screening Mammography Module Created for Instruction and Assessment: Radiology Residents vs National Benchmarks.
Poot JD; Chetlen AL
Acad Radiol; 2016 Nov; 23(11):1454-1462. PubMed ID: 27637285
[TBL] [Abstract][Full Text] [Related]
10. Performance Benchmarks for Screening Breast MR Imaging in Community Practice.
Lee JM; Ichikawa L; Valencia E; Miglioretti DL; Wernli K; Buist DSM; Kerlikowske K; Henderson LM; Sprague BL; Onega T; Rauscher GH; Lehman CD
Radiology; 2017 Oct; 285(1):44-52. PubMed ID: 28582633
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
Kwon MR; Choi JS; Won H; Ko EY; Ko ES; Park KW; Han BK
Radiology; 2021 Apr; 299(1):73-83. PubMed ID: 33620293
[TBL] [Abstract][Full Text] [Related]
12. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
[TBL] [Abstract][Full Text] [Related]
13. Performance benchmarks for screening mammography.
Rosenberg RD; Yankaskas BC; Abraham LA; Sickles EA; Lehman CD; Geller BM; Carney PA; Kerlikowske K; Buist DS; Weaver DL; Barlow WE; Ballard-Barbash R
Radiology; 2006 Oct; 241(1):55-66. PubMed ID: 16990671
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.
Lee CI; Ichikawa L; Rochelle MC; Kerlikowske K; Miglioretti DL; Sprague BL; DeMartini WB; Wernli KJ; Joe BN; Yankaskas BC; Lehman CD
Acad Radiol; 2014 Nov; 21(11):1370-6. PubMed ID: 25126973
[TBL] [Abstract][Full Text] [Related]
15. Breast Magnetic Resonance Imaging Audit: Pitfalls, Challenges, and Future Considerations.
Lam DL; Lee JM
Radiol Clin North Am; 2021 Jan; 59(1):57-65. PubMed ID: 33223000
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
17. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
18. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
[TBL] [Abstract][Full Text] [Related]
19. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
Baltzer PAT; Bennani-Baiti B; Stöttinger A; Bumberger A; Kapetas P; Clauser P
Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
